Financing - August 26, 2019
Umeå Biotech Incubator to receive SEK 10 million research grant
Umeå Biotech Incubator (UBI) has been named the only incubator in the Nordic region to once again be granted funding from the prestigious Erling Persson Family Foundation. UBI is being granted SEK 10 million between 2020-2022 to help researchers commercialise their ideas for the greater benefit of society. It is the third time UBI has […]
Clinical Trials - August 26, 2019
Positive preclinical data from Cantargia
The company has announced new positive preclinical data which defines a novel additional development opportunity for Cantargias antibody CAN04. The molecular target for CAN04, IL1RAP, has been detected on the cancer cells in approximately 80 % of patients with bladder cancer. Furthermore, a pronounced and statistically significant single agent activity was documented in an in […]
In a new job - August 21, 2019
LIDDS has appointed a new CFO
The company has appointed Anja Peters Ohlsson as new CFO of LIDDS AB and member of the management team. Anja will succeed Bengt Norvik, who will leave his position in September following many years as CFO of the company. Anja holds a Major in Accounting and Finance from Uppsala University. Previous positions include CFO of […]
Uncategorized - August 19, 2019
Researchers have discovered a new pain organ in the skin
Researchers at Karolinska Institutet in Sweden have discovered a new sensory receptor organ that is able to detect painful mechanical damage, such as pricks and impacts. Pain causes suffering and results in substantial costs for society. Almost one person in every five experiences constant pain and there is a considerable need to find new painkilling […]
Profiles in Pharma - August 15, 2019
Katarina Ageborg, CEO AstraZeneca Sweden
Few companies are as synonymous with Sweden as AstraZeneca and few CEOs as visible. Yet, Katarina Ageborg, AstraZeneca Sweden’s new CEO, prefers not to think about being center stage, but instead about what her position can do for the company, Sweden and the pharmaceutical industry as a whole. “I don’t think about it that way […]
Financing - August 13, 2019
InfiCure Bio receives additional funding
The company has received additional funding from NLC InfiCure Bio and Partnerinvest Övre Norrland. The funding will be used to speed up the validation of additional indications in the NIF mouse, states the company. “This is a golden opportunity to broaden our customer base and increase the revenue of the company,” it says in its […]